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C. v a n  W eel
Departments of GeneraI Practice and Social Medicine and * Pulmonary Diseases, Faculty of Medical
Sciences, University of Nijmegen, The Netherlands
Objectives: to study the relationship between chronic respiratory symptoms and bronchial hyperresponsive­
ness (BHR) in adolescence and young adulthood and to assess the possible predictive value of these symptoms 
for BHR.
Methods: a cross-sectional analysis: in a population sample of 551 subjects aged 10-23 years, data collected 
with a standardized questionnaire on respiratory symptoms were compared with the results of a histamine 
challenge test.
Results: 43% of the subjects reported one or more chronic respiratory symptoms; of these subjects 54% did 
not show BHR. Forty-two per cent of the subjects had a PC20 ^ S - O m g m P 1 histamine, of which 53%) 
reported no chronic respiratory symptoms. Wheezing and breathlessness were related to the level of BHR, but 
only ‘breathless when walking on the flat1 was independently related to BHR; however, its predicted value for 
BHR was negligible.
Conclusions: in adolescents and young adults the relationship between chronic respiratory symptoms and 
BHR is incomplete. A standardized questionnaire on respiratory symptoms does not provide adequate 
information to discriminate between those with and without BHR.
Introduction
In estimating the prevalence of asthma it is not 
acceptable to rely on the general practitioner’s diag­
nosis only, since a substantial number of patients 
with asthma might not be recognized in general 
practice (1,2). Therefore, in epidemiologic surveys 
standardized questionnaires on respiratory symp­
toms have been used to assess the prevalence of this 
condition. This method, however, lacks validity due 
to the weakness of the relation between symptoms 
and airways obstruction (3,4) and to differences in 
interpretation of the questions.
The need for a more objective marker of asthma 
seemed to be satisfied by the recognition of bronchial 
hyperresponsiveness (BHR) as a hallmark of asthma 
(5-8). However, BHR is not specific to asthma
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because it has been demonstrated in patients with 
chronic airflow obstruction (9), rhinitis (5) and upper 
respiratory tract infections (10), Moreover, this view­
point has been questioned on the basis of the results 
of studies in unselected populations (11-15) which 
focused on the relation between respiratory symp­
toms and BHR, These studies showed a considerable 
overlap of BHR between subjects with and without 
symptoms.
As a consequence, the predictive values of the 
symptoms to BHR were unsatisfactory and, there­
fore, the standardized questionnaires used failed to 
discriminate between subjects with and without BHR
(16,17).
Most studies were based on populations of chil­
dren or adults, whereas the diagnosis and treatment 
of asthma are problematic in adolescence and young 
adulthood as well.
This study examines the relationship between 
chronic respiratory symptoms and BHR in a 
community-based population sample of subjects aged 
10-23 years, and the usefulness of the standardized 
questionnaire for assessing BHR.
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Materials and Methods
This study was a cross-sectional analysis of chronic 
respiratory symptoms and BHR in 581 10-23-year- 
old subjects. The study was part of a foilow-up study 
of the relationship between respiratory morbidity in 
early childhood and asthma in adolescence and 
young adulthood (18).
STUDY POPULATION
The subjects of this study were recruited from the 
practice population of the Continuous Morbidity 
Registration (CMR) of the Department of General 
Practice of the University of Nijmegen. The charac-
n
teristics of this registration project have been 
described in detail elsewhere (19,20). Briefly, this 
project includes four general practices with a stable 
population of 12 000 persons, whose sociodemo­
graphic composition and morbidity spectrum do not 
differ essentially from those of the Dutch population. 
All subjects of the practice lists of the four CMR- 
practices, who were born between 1967 (the year the 
CMR-project started) and 1978 («=1441) and who 
were still on these practice lists at the time of this 
study in 1989, were invited to participate. The study 
was confined to subjects born before 1979 to guaran­
tee a follow-up period from birth of at least 10 yr for 
the above-mentioned follow-up study. There were 
926 subjects (64% of the original birth cohorts) who 
met these criteria, 484 boys and 442 girls, aged 10-23 
years at the time of this study (hereafter referred to as 
‘adolescents and young adults’). Before the start of 
this study 515 subjects had left the practices; 492 had 
moved with their families to another area; 23 children 
had died, none of them as a consequence of 
respiratory disease.
The 926 subjects (where subjects were younger 
than 16, also their parents) were given written and 
oral explanations and they were asked to complete a 
respiratory questionnaire and to undergo spirometry 
and a histamine-challenge test.
Of this group 581 subjects (63%) gave informed 
consent and participated in this study. Of 551 sub­
jects all the necessary data were available (study 
group).
The following information was collected in a 
survey in the winter of 1989-1990:
(a) Questionnaire on respiratory symptoms:
The questionnaire was based on the standard­
ized questionnaire on respiratory symptoms 
(children’s version) of the British Medical 
Research Council (BMRC) and the American 
Thoracic Society (ATS) (21). Its reproducibility 
and criterion-validity had been found satisfactory
(22,23).
Questions on age, sex and smoking behaviour 
were added. The questions on chronic respiratory 
symptoms are listed in Appendix A, together 
with the questions on smoking behaviour. 
Asthma symptoms were considered present in 
case of an affirmative answer to at least one of 
questions numbered 1, 3, 4 or 5.
All subjects completed the questionnaire them­
selves.
(b) Allergy to inhalant allergens was assessed by the 
Phadiatop-test (Kabi Pharmacia Diagnostics AB, 
Uppsala, Sweden) (24). The test was considered 
positive when the ratio (patient’s serum/reference 
serum) was higher than 1.
(c) Spirometry and histamine-challenge protocol: 
Spirometry was carried out with a Microspiro 
HI-298, a portable flow-volume meter (Chest 
Corporation, Tokyo, Japan) (25). Each patient 
had to perform three satisfactory forced vital 
capacity (FVC) manoeuvres (values within 10% 
of each other). Data were taken from the highest 
sum of FVC and the forced expiratory volume in 
one second (FEVj).
Subjects who had a FEV, < (FEVj 
predicted — 2sd) (26,27) were considered to have 
airways obstruction.
Subjects who had a baseline FEV! <50% of 
their FEVj predicted, or less than 1 1, were 
excluded from the histamine-challenge test.
PC20-histamine was assessed by means of the 
concise version of the tidal breathing procedure 
of Cockcroft et al. (28). Following an inha­
lation of saline, histamine concentrations from
0 03—16 mg m l“ 1 were inhaled.
Bronchodilators and anti-histamines, when 
used, were withheld at least 8 and 48 h respec­
tively before the test. When a subject had had a 
respiratory tract infection with fever a short time 
before, the test was postponed for 6 weeks. 
Results were expressed as the concentration of 
histamine required to produce a 20% fall in FEVj 
(PC2Ü). Subjects with a PC20 <8-0 mg ml 1 were 
considered to have bronchial hyperresponsive­
ness.
ANALYSIS
In order to analyse whether the study group was a 
representative sample of the original birth cohorts, 
socio demo graphic features of the 551 subjects of the 
study group were compared with those of the original 
birth cohorts who did not belong to the study group.
Univariate analyses were made to determine 
whether there were relations between each of the 
chronic respiratory symptoms separately on the one
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hand and BHR on the other. The relations of age, sex 
and smoking status to BHR were studied as well. 
Age, number of chronic respiratory symptoms and 
smoking status were used as categorical variables; sex 
and each respiratory symptom separately were used 
as dichotomous variables. BHR was handled in both 
ways: as a dichotomous outcome variable and as an 
outcome variable categorized according to criteria 
previously determined in clinical studies of asthmatic 
subjects (8).
The chi-square test and the Wilcoxon test for trend 
were used to determine the significance of the 
relations.
Then a multiple logistic regression analysis was 
carried out. This analysis involved finding the ‘best’ 
mathematical model (in this case in a logistic form, 
since the outcome variable BHR was handled as a 
dichotomous variable) to describe a dependent vari­
able as a function of several independent variables or 
to predict the dependent variable from these indepen­
dent variables (29,30). Here it was used to identify 
chronic respiratory symptoms that were indepen­
dently related to BHR, controlling for the other 
chronic respiratory symptoms, age, sex, smoking 
status, prechallenge FEV, and allergy as potentially 
confounding factors. In addition, to assess the pre­
dictive values of these symptoms to BHR, the best 
model was constructed with only these symptoms 
and the other factors that related significantly to 
BHR as independent factors. The goodness of fit of 
this model (concordance, discordance) was deter­
mined to judge whether it explained sufficient vari­
ance of BHR to be useful for assessing the predictive 
values. The predictive value in the case of the pres­
ence of a symptom was defined as the proportion 
of subjects with that symptom who had BHR, and 
the predictive value in the case of the absence 
of a symptom was defined as the proportion of 
subjects without that symptom who did not have 
BHR (31).
The regression analysis was repeated after stratifi­
cation for prechallenge FEV, and allergy to examine 
the effect of these factors on the relations between 
chronic respiratory symptoms and BHR.
Finally, the regression analysis was repeated using 
more restrictive definitions of BHR, viz. successively 
BHR in case of PC2(, <4*0 and in case of 
<2-0 mg ml ~ *.
All analyses were performed using the SAS 
statistical package (SAS Institute Inc, Cary, NC, 
U.S.A.).
Permission for the study was given by the 
Ethics Committee of the Faculty of Medicine of the 
University of Nijmegen.
Results
The data of 30 of the 581 subjects who participated 
in this study were excluded from the analysis; three 
subjects were not able to perform reproducible forced 
expiratory manoeuvres, seven could not finish the 
challenge test due to coughing, although FEV, was 
not significantly decreased, and 20 subjects did not 
complete the questionnaire satisfactorily. None of the 
subjects had an initial FEV, <50% of FEV, pre­
dicted, or <11, so all 551 participants underwent the 
histamine challenge test.
The comparison between the study group and 
those of the original birth cohorts who did not belong 
to the study group showed that of the study group 
(statistically) significantly fewer subjects belonged to 
the higher social class and were men than of the latter 
group. No differences were found with respect to age.
Of the subjects, 43% reported one or more chronic 
respiratory symptom and 26% one or more asthma 
symptom. BHR was found in 40% of those without 
asthma symptoms, increasing to 51% in those who 
reported two or more asthma symptoms (P=0*14).
The overall prevalence of BHR was 42%. Neither 
sex nor age were related to it.
Of the study group 18% smoked, 5% had stopped 
smoking and 77% had never smoked. BHR was 
found in 34, 40 and 44% respectively (P=0T7).
Table 1 shows the prevalence of the chronic respir­
atory symptoms and their relation to the prevalence 
of BHR. Only the symptoms of ‘quicker breathless 
than people of the same age5 and ‘breathless when 
walking on the flat’ had a statistically significantly 
higher prevalence in the group with BHR.
Of those who reported one or more asthma symp­
tom, 51% did not show BHR (54% for chronic 
respiratory symptoms). Of those with BHR 70% did 
not report asthma symptoms (53% had no chronic 
respiratory symptoms).
The prevalence of chronic respiratory symptoms in 
relation to the degree of BHR is shown in Table 2. In 
general the higher the degree of BHR, the higher the 
prevalence of each respiratory symptom. However, 
the differences between those with mild BHR and 
those without BHR were small.
The relationship between the likelihood of a posi­
tive histamine challenge test and chronic respiratory 
symptoms was examined in a multiple logistic regres­
sion model, which included sex, age, smoking status, 
prechallenge FEV, and allergy. Of the symptoms 
only ‘breathless when walking on the fiat’ (Odds 
Ratio [OR] = 3-9; 95% confidence intervals fCI] = 1 *5— 
10*7; P-value=0-007) turned out to be independently 
related to BHR. Also prechallenge FEV, (OR =1*9;
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Ttf/jfc / Prevalence of chronic respiratory symptoms in the total study group and by histamine 
challenge lest (HCT) response*
Respiratory symptoms
Whole study 
group 
« = 551
Positive1
HCT
«=232
Negative
HCT 
« = 319 OR 95% Cl P-va lue
Chronic cough 28 (5) 14(6) 14 (4) 1*4 0-7-3‘0 0*4
Chronic phlegm 22 (4) 9 (4) 13 (4) 1-0 0-4-2 *3 0*9
Chronic cough/phlegm 37 (7) 19 (8) IS (6) 1-5 0-8-29 0-3
Wheezing 106 (19) 52 (22) 54 (17) 1-4 0-9-2-2 0-1
Tightness/wheezing 60 (11) 30 (13) 30 (9) 1-4 0*8-2-5 0-2
Breath less/age 72 (13) 42(18) 30 (9) 2-1 1 *3-3*5 0-003
Brealhless/upstairs 150 (27) 68 (29) 32 (26) 1*2 0-8-18 0-3
Breath less/flat 24 (4) 16(7) 8(3) 2 9  1-2-6-9 0-01
Any asthma symplomb 143 (26) 70 (30) 73 (23) 1-5 1-0-2-1 0-05
^Results are presented as numbers of subjects (column percentages in parentheses).
Cl, confidence interval.
\  Positive if PC2(> <8*0 mg ml" l.
b, in case of an affirmative answer to at least one of the questions on ‘chronic cough’, ‘chronic
cough with phlegm', ‘wheezing’ and ’tightness with wheezing1.
Table 2 Prevalence rates ol' chronic respiratory symptoms in each grade of bronchial
responsiveness (BR)*
Degree of BR; PC2() grouping (mg ml l)
Severe Moderate Mild N o BHR
0-0*5 I “2 4-8 >  16
« = 35 «=41 «=156 « = 319
Respiratory symptoms 6% 7% 28% 58% P-valueb
Chronic cough 6 7 6 4 0-37
Chronic phlegm 6 2 4 4 0*95
Chronic cough/phlegm 20 5 6 6 0-10
Wheezing 54 29 14 17 0-003
Tightness/wheezing 31 6 9 0*0!
Breathless/age 51 22 10 9 <0-001
Breathless/upstairs 49 32 24 26 0-U
Breathless/flat 11 0 8 3 002
Any asthma symptom11 57 39 22 23 0-004
« = 551.
*Data are percentages of total in each column.
in case of an affirmative answer to at least one of the questions on ‘chronic cough', ‘chronic 
cough with phlegm', ‘wheezing’ and ‘tightness with wheezing’. 
h, Wilcox on test for trend.
C l= H  -3• 1 ; P =0*02) and allergy (OR = 1 - 7; Cl = 1 *2- 
2*4; P = 0*007) were independently related to BHR. 
However, the goodness of fit of the model including 
only the variables independently related to BHR had 
limited value (concordance 51%, discordance 26%). 
Therefore, there was no use assessing the predictive 
values of these factors for BHR. Both after stratifi­
cation for FEV I and for allergy the odds ratios of the 
variables did not change significantly. However, in
the case of airways obstruction [FEV, < (FEV, 
predicted — 2s d ) ]  all six subjects who had reported 
getting breathless when walking on the fiat were 
hyperresponsive.
When the PC2n-values 4-0 and 2*0 mg ml 1 were 
chosen as cutoff points (BHR considered present in 
case of PC2Ü <4-0 or in case of <2-0 mg ml ~ '), the 
overall prevalence of BHR was 24% and 14%, respec­
tively. Repetition of the multiple logistic regression
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analysis with use of these lower PC20-values as cutoff 
points showed that ‘breathless when walking on the 
flat’ was no longer significantly related to BHR 
(OR=2-4; CI=0-8~6’5; P=0*08, and 0R=O4; 
C l= 0 T -1-8; P=  0-23, respectively). At these cutoff 
points 'quicker breathless than people of the same 
age’ became significantly related to BHR (OR=3*4; 
Cl — 1 -9—6’ 1 ; P<0-001, and OR = 3*5; CI=l-8-6*6; 
P<0-001, respectively). Again, in both cases the 
goodness of lit of the models was not sufficient to 
allow a useful assessment of predictive values, and 
stratification did not show a significant effect of 
prechallenge FEV, or allergy on the relation found.
Discussion
This study reports the results of an analysis of the 
relation between chronic respiratory symptoms and 
BHR in adolescents and young adults. Most chronic 
respiratory symptoms were related to (the severity of) 
BHR. However, after controlling several interacting 
factors, only ‘breathless when walking on the flat' 
and ‘quicker breathless than people of the same age1 
were statistically significantly related to BHR. Which 
of these symptoms was related to BHR depended on 
the definition of BHR (i.e. on the PC20-value used as 
cutoff point beyond which subjects are considered 
hyperresponsive). These results were not dependent 
on the presence of allergy to inhalant allergens nor on 
the presence of airways obstruction. The predictive 
values of the symptoms for BHR were negligible. A 
substantial number of those with asthma symptoms 
did not show BHR, and a substantial number of 
those with BHR did not report asthma symptoms.
It was demonstrated that it is possible to determine 
the prevalence and severity of BHR in a large popu­
lation of adolescents and young adults by means of a 
concise version of Cockcroft’s histamine challenge 
test. No serious side-effects of the test were observed.
The prevalence of ‘any asthma symptom’ found in 
this study was higher than most of those reported in 
other studies, in which the highest estimates approxi­
mate to 34% (13). However, it is difficult to compare 
the findings because in almost every study the symp­
toms considered as asthma symptoms differ, the age 
groups differ, and other questionnaires are used.
For each symptom the prevalence figures were two 
to five times higher than those assessed with the same 
questionnaire in a survey of schoolchildren aged 6-12 
(23). This may be due to differences in age category 
and to the fact that in that study the parents com­
pleted the questionnaire whereas in the present study 
the questionnaire was completed by the adolescents 
and young adults themselves (32).
The prevalence of BHR found in this study was 
higher than that reported in other population-based 
studies of children and adolescents, ranging from 
16-23%) (11-13,33), but also values of 4% in adoles­
cents aged 11-17 years (34) and 64% in students aged 
20-29 years (35) are reported. The differences in 
age distribution and in methods of measuring and 
defining BHR (other cutoff points) may partly 
explain these discrepancies. In this respect the present 
study can best be compared with that of Cockcroft 
and colleagues (35) (64% of subjects with PC2{) 
<8-0 mg ml" ') and that of Backer and colleagues 
(36) (16% of subjects aged 7-16 years with PC20 
<8-0 mg ml ~ l)<
Our study group originated from birth cohorts of 
four general practices. The comparison of this group 
with those of the original birth cohorts who did not 
participate in the study showed that there was a small 
but statistically significant selection tending towards 
lower social class and female sex. Since morbidity 
figures are higher in lower social classes (37), the 
prevalence of symptoms and BHR may be overesti­
mated, As these differences between the study group 
and those of the original birth cohorts who did not 
participate in the study were small, their influence on 
the results will have been limited. Selection bias will 
not have influenced the results of the analysis of the 
relationship between symptoms and BHR either. 
These high figures were probably not the result of 
recent respiratory infections either, since in that case 
the histamine challenge test was postponed for 6 
weeks. Most tests were performed in December and 
January, thus avoiding the influence of the grass 
pollen season (38), Method failure seems to be an 
unlikely explanation as a standardized method was 
used (28) with regular calibration of the meters and 
nebulizers. Poor motivation in performing spi­
rometry may have influenced the results, though the 
data of inadequately performed forced expiratory 
manoeuvres were excluded from the analysis.
The severity of BHR was closely related to wheez­
ing and breathlessness, but not to cough. Most other 
studies found wheezing to be related to BHR as well 
(12-15,17,39). In a few studies, coughing has also 
been shown to be related to BHR (12,39). No rela­
tionship was found between BHR and sex, which is 
consistent with other investigations (11,14), but in 
contrast to other studies (11) BHR was not related .to 
age either.
Since the predictive value of symptoms to BHR 
was negligible, it can be concluded that the standard­
ized questionnaire was unable to discriminate 
between adolescents and young adults with and with­
out BHR. These results are consistent with those of
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studies with other standardized questionnaires in 
other age groups (16,17).
The finding that a substantial number of those with 
asthma symptoms did not show BHR has been found 
in other studies as well (12-14,33). The significance of 
asthma symptoms without BHR is not clear. 
Recently evidence has been provided that children 
with wheezing but without BHR show similar char­
acteristics to asymptomatic non-hyperresponsive 
children (40), and this was confirmed after a 1-yr 
follow-up (41). This points to the fact that studies on 
the prevalence of asthma which only rely on data 
from questionnaires on these symptoms, are likely to 
overestimate its prevalence.
Of all subjects with BHR, 70% did not report 
asthma symptoms. Asymptomatic BHR has been 
found in other studies as well (11-14,33). Those 
with asymptomatic BHR may run a higher risk of 
developing asthma in later life (42). Hopp and col­
leagues found that BHR usually precedes the onset of 
asthma (43).
Long term follow-up studies on the course and 
prognosis of asymptomatic BHR and asthma symp­
toms without BHR may clarify the significance of 
these phenomena. The results of these studies may 
contribute to answering the question on the basis of 
which criteria the diagnosis of asthma should be 
established in screening surveys. The presence of both 
wheezing and BHR has recently been recommended 
as criteria in this respect (40). This is consistent with 
the recently published International Consensus 
Report on Diagnosis and Treatment of Asthma (44). 
Therefore, further research is needed to develop stan­
dardized questionnaires, which are more valid for 
BHR, e.g. by adding questions more specific to BHR, 
dealing with the symptomatic response to different 
stimuli (cold air, dust, exercise, chemical irritants).
In summary, there were two main findings in this 
study of a community based sample of subjects aged 
10-23 years; firstly, of several chronic respiratory 
symptoms only ‘breathless when walking on the flat* 
was independently related to BHR, but its predictive 
value for BHR was negligible; and secondly, of the 
subjects who showed BHR 70% did not report any 
asthma symptom, whereas 51% of those with one or 
more asthma symptoms did not show BHR.
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Appendix Ä
QUESTIONNAIRE
1. Chronic cough: did you usually -  at least 5 days a 
week -  cough (e.g. when getting up, or during the 
day or at night) for at least three consecutive 
months?
2. Chronic phlegm: did you usually -  at least 5 days 
a week-bring up phlegm (e,g. when getting up, 
or during the day, or at night) for at least three 
consecutive months?
3. Chronic cough with phlegm: have you coughed 
up phlegm, more than usual, for at least three 
consecutive weeks in the last 12 months?
4. Wheezing: have you had wheezing in your chest 
in the last 12 months?
5. Tightness with wheezing: have you had attacks of 
tightness with wheezing in your chest (attacks of 
asthma) in the last 12 months?
6. Breathless/age: do you think that you get breath­
less more quickly than friends of your own age?
7a. Breathless/upstairs: have you been breathless 
going upstairs or riding a bike at a normal pace 
at least once in the last 12 months?
7b. Breathless/flat: if yes, have you been breathless 
when you walked on the flat at a normal pace at 
least once in the last 12 months?
8. Smoking behaviour: do you smoke? Have you 
ever smoked, but did you stop smoking?
